Report cover image

Europe Alpha and Beta Emitters Based Radiopharmaceuticals Market

Publisher Data Bridge Market Research
Published Jun 01, 2025
Length 350 Pages
SKU # DAABD20406980

Description

The Europe alpha and beta emitters based radiopharmaceuticals market is expected to reach USD 465.84 million by 2032 from USD 215.99 million in 2024, growing with a substantial CAGR of 10.1% in the forecast period of 2025 to 2032.

Market Segmentation:
Europe Alpha and Beta Emitters Based Radiopharmaceuticals Market, By Isotope (Beta Emitters and Alpha Emitters), Sources (Reactor-Produced Isotopes, Generator-Produced Isotopes, and Others), Therapeutic Application (Oncology and Others), Vector Type (Small Molecule Ligands, Peptides, Monoclonal Antibodies, and Others), End User (Hospitals, Radiopharmacies, and Research Institutes), Country (Germany, U.K., France, Italy, Spain, Switzerland, Russia, Turkey, Netherlands, Poland, Norway, Austria, Ireland, and Rest of Europe) - Industry Trends and Forecast to 2032
Overview of Europe Alpha and Beta Emitters Based Radiopharmaceuticals Market Dynamics:
Drivers
• Increased efficacy of targeted alpha and beta therapies
• Growing adoption of theranostics in personalized medicine
Restraints
• Supply chain and scalability challenges from short isotope half-lives
• Stringent regulatory landscape limiting market flexibility
Opportunities
• Surge in R&D activity expanding radiopharmaceutical applications
• Expansion of Lu-177-PSMA therapy in prostate cancer treatment
Market Players:
The key players operating in the Europe alpha and beta emitters based radiopharmaceuticals market are:
• Novartis AG
• Eckert & Ziegler
• ITM Isotope Technologies Munich SE
• SHINE Technologies, LLC
• Actinium Pharmaceuticals, Inc.
• ARICEUM THERAPEUTICS
• Bayer AG
• Curium
• Isotopia
• Lantheus
• Lilly
• Oncoinvent
• Orano Group
• Telix Pharmaceuticals Limited
• Terthera


Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.

Table of Contents

350 Pages
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market
1.4 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Currency And Pricing
2.5 Dbmr Tripod Data Validation Model
2.6 Multivariate Modelling
2.7 Primary Interviews With Key Opinion Leaders
2.8 Dbmr Market Position Grid
2.9 Vendor Share Analysis
2.10 End User Market Coverage Grid
2.11 Secondary Sources
2.12 Assumptions
3 Executive Summary
4 Premium Insight
4.1 Porter’s Five Forces
4.2 Pestel Analysis
4.3 Pipeline
4.4 Supply Chain Ecosystem
4.4.1 Prominent Companies
4.4.2 Small & Medium Size Companies
4.4.3 End Users
4.5 Industry Insights
4.5.1 Micro And Macro Economic Factors
4.5.2 Key Pricing Strategies
4.6 Marketed Drug Analysis
4.6.1 Drug
4.6.1.1 Brand Name
4.6.1.2 Generic Name
4.6.2 Therapeutic Indication
4.6.3 Pharmacological Class Of The Drug
4.6.4 Drug Primary Indication
4.6.5 Market Status
4.6.6 Medication Type
4.6.7 Drug Dosage Form
4.6.8 Dosages Availability
4.6.9 Packaging Type
4.6.10 Drug Route Of Administration
4.6.11 Dosing Frequency
4.6.12 Drug Insight
4.6.13 Overview Of Drug Development Activities
4.6.13.1 Forecast Market Outlook
4.6.13.2 Cross Competition
4.6.13.3 Therapeutic Portfolio
4.6.13.4 Current Development Scenario
4.7 Healthcare Tariffs Impact Analysis
4.7.1 Overview
4.7.2 Tariff Structures
4.7.2.1 Europe Vs. Regional Tariff Structures
4.7.2.2 United States: Medicare/Medicaid Tariff Policies, Cms Pricing Models
4.7.2.3 European Union: Cross-border Tariff Regulations, Reimbursement Policies
4.7.2.4 Asia-pacific: Government-imposed Tariffs On Imported Medical Products
4.7.2.5 Emerging Markets: Challenges In Tariff Implementation
4.7.3 Pharmaceutical Tariffs And Trade Barriers
4.7.3.1 Import Duties On Prescription Drugs Vs. Generics
4.7.3.2 Impact On Drug Affordability And Access
4.7.3.3 Key Trade Agreements Affecting Pharmaceutical Tariffs
4.8 Impact Of Healthcare Tariffs On Providers And Patients
4.8.1.1 Cost Burden On Hospitals And Healthcare Facilities
4.8.1.2 Effect On Patient Affordability And Insurance Coverage
4.8.1.3 Tariffs And Their Role In Medical Tourism
4.8.2 Trade Agreements And Healthcare Tariffs
4.8.2.1 Wto Regulations On Healthcare Tariffs
4.8.2.2 Impact Of Trade Wars On The Healthcare Supply Chain
4.8.2.3 Role Of Free Trade Agreements (Ftas) In Reducing Tariffs
4.8.3 Impact Of Tariffs On Healthcare Costs And Accessibility
4.8.4 Importance Of Tariffs In The Healthcare Sector
4.9 Epidemiology Overview
4.9.1 Incidence Of All Cancers By Gender
4.9.2 Treatment Rate
4.9.3 Mortality Rate
4.9.4 Drug Adherence And Therapy Switch Model
4.9.5 Patient Treatment Success Rates
5 Regulatory Framework
5.1 Regulatory Framework Overview For The Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market
5.1.1 Geographies’ Ease Of Regulatory Approval
5.1.2 Regulatory Approval Pathways
5.1.3 Licensing And Registration
5.1.4 Post-marketing Surveillance
5.1.5 Good Manufacturing Practices (Gmps) Guidelines
6 Market Overview
6.1 Drivers
6.1.1 Increased Efficacy Of Targeted Alpha And Beta Therapies
6.1.2 Growing Adoption Of Theranostics In Personalized Medicine
6.1.3 Rising Clinical Demand For Alpha-based Radiotherapies
6.1.4 Rising Chronic Disease Burden Driving Radiopharmaceutical Demand
6.2 Restraints
6.2.1 Supply Chain And Scalability Challenges From Short Isotope Half-lives
6.2.2 Stringent Regulatory Landscape Limiting Market Flexibility
6.2.3 Safety And Exposure Risks In Radiopharmaceutical Use
6.3 Opportunities
6.3.1 Surge In R&D Activity Expanding Radiopharmaceutical Applications
6.3.2 Expansion Of Lu-177-psma Therapy In Prostate Cancer Treatment
6.3.3 Strategic Collaborations Driving Radiopharmaceutical Innovation
6.4 Challenges
6.4.1 High Cost Of Development And Implementation Of Radiopharmaceuticals
6.4.2 Shortage Of Skilled Workforce In Nuclear Medicine And Radiochemistry
7 Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Isotope
7.1 Overview
7.2 Beta Emitters
7.2.1 Lutetium-177
7.2.2 Terbium-161
7.3 Alpha Emitters
7.3.1 Actinium-225
7.3.2 Lead -212
8 Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Sources
8.1 Overview
8.2 Reactor-produced Isotopes
8.3 Generator-produced Isotopes
8.4 Others
9 Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Therapeutic Application
9.1 Overview
9.2 Oncology
9.2.1 Prostate Cancer
9.2.2 Neuroendocrine Tumors
9.2.3 Liver Cancer
9.2.4 Brain Tumors
9.2.5 Breast Cancer
9.2.6 Leukemia
9.3 Others
10 Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Vector Type
10.1 Overview
10.2 Small Molecule Ligands
10.3 Peptides
10.4 Monoclonal Antibodies
10.5 Others
11 Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market, By End User
11.1 Overview
11.2 Hospitals
11.2.1 Oncology Centers
11.2.2 Nuclear Medicine Departments
11.3 Radiopharmacies
11.4 Research Institutes
12 Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Region
12.1 Europe
12.1.1 Germany
12.1.2 U.K.
12.1.3 France
12.1.4 Italy
12.1.5 Spain
12.1.6 Poland
12.1.7 Russia
12.1.8 Norway
12.1.9 Turkey
12.1.10 Austria
12.1.11 Ireland
12.1.12 Netherlands
12.1.13 Switzerland
12.1.14 Rest Of Europe
13 Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market: Company Landscape
13.1 Company Share Analysis: Europe
14 Swot Analysis
15 Company Profiles
15.1 Novartis Ag
15.1.1 Company Snapshot
15.1.2 Revenue Analysis
15.1.3 Company Share Analysis
15.1.4 Product Portfolio
15.1.5 Recent Developments
15.2 Eckert & Ziegler
15.2.1 Company Snapshot
15.2.2 Revenue Analysis
15.2.3 Company Share Analysis
15.2.4 Product Portfolio
15.2.5 Recent Developments
15.3 Itm Isotope Technologies Munich Se
15.3.1 Company Snapshot
15.3.2 Company Share Analysis
15.3.3 Product Portfolio
15.3.4 Recent Development
15.4 Shine Technologies, Llc
15.4.1 Company Snapshot
15.4.2 Company Share Analysis
15.4.3 Product Portfolio
15.4.4 Recent Development
15.5 Actinium Pharmaceuticals, Inc.
15.5.1 Company Snapshot
15.5.2 Pipeline Product Portfolio
15.5.3 Recent Developments
15.6 Alpha Tau Medical Ltd.
15.6.1 Company Snapshot
15.6.2 Pipeline Product Portfolio
15.6.3 Recent Development
15.7 Ariceum Therapeutics
15.7.1 Company Snapshot
15.7.2 Pipeline Product Portfolio
15.7.3 Recent Development
15.8 Bayer Ag
15.8.1 Company Snapshot
15.8.2 Revenue Analysis
15.8.3 Pipeline Product Portfolio
15.8.4 Recent Development
15.9 Curium
15.9.1 Company Snapshot
15.9.2 Pipeline Product Portfolio
15.9.3 Recent Development
15.10 Ionetix Corporation
15.10.1 Company Snapshot
15.10.2 Pipeline Product Portfolio
15.10.3 Recent Development
15.11 Isotopia
15.11.1 Company Snapshot
15.11.2 Pipeline Product Portfolio
15.11.3 Recent Development
15.12 Lantheus
15.12.1 Company Snapshot
15.12.2 Revenue Analysis
15.12.3 Pipeline Product Portfolio
15.12.4 Recent Development
15.13 Lilly
15.13.1 Company Snapshot
15.13.2 Revenue Analysis
15.13.3 Pipeline Product Portfolio
15.14 Niowave
15.14.1 Company Snapshot
15.14.2 Pipeline Product Portfolio
15.14.3 Recent Development
15.15 Nmr
15.15.1 Company Snapshot
15.15.2 Pipeline Product Portfolio
15.15.3 Recent Development
15.16 Oncoinvent
15.16.1 Company Snapshot
15.16.2 Pipeline Product Portfolio
15.16.3 Recent Development
15.17 Orano Group
15.17.1 Company Snapshot
15.17.2 Revenue Analysis
15.17.3 Pipeline Product Portfolio
15.17.4 Recent Development
15.18 Radiopharm Theranostics Limited
15.18.1 Company Snapshot
15.18.2 Pipeline Product Portfolio
15.18.3 Recent Development
15.19 Telix Pharmaceuticals Limited
15.19.1 Company Snapshot
15.19.2 Revenue Analysis
15.19.3 Pipeline Product Portfolio
15.19.4 Recent Development
15.20 Terthera
15.20.1 Company Snapshot
15.20.2 Pipeline Product Portfolio
15.20.3 Recent Development
15.20.4 Recent Development
16 Questionnaire
17 Related Reports
List Of Tables
Table 1 Europe Clinical Trial Market For Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market
Table 2 Distribution Of Products And Projects By Phase Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market
Table 3 Distribution Of Projects By Therapeutic Area And Phase Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market
Table 4 Distribution Of Projects By Scientific Approach And Phase Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market
Table 5 Penetration And Growth Prospect Mapping
Table 6 Incidence Of Cancer By Gender
Table 7 Cancer Mortality Rate
Table 8 Cancer Treatment Success Rate
Table 9 Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Isotope, 2018-2032 (Usd Thousand)
Table 10 Europe Beta Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Region, 2018-2032 (Usd Thousand)
Table 11 Europe Beta Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
Table 12 Europe Alpha Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Region, 2018-2032 (Usd Thousand)
Table 13 Europe Alpha Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
Table 14 Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Sources, 2018-2032 (Usd Thousand)
Table 15 Europe Reactor-produced Isotopes In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Region, 2018-2032 (Usd Thousand)
Table 16 Europe Generator-produced Isotopes In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Region, 2018-2032 (Usd Thousand)
Table 17 Europe Others In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Region, 2018-2032 (Usd Thousand)
Table 18 Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Therapeutic Application, 2018-2032 (Usd Thousand)
Table 19 Europe Oncology In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Region, 2018-2032 (Usd Thousand)
Table 20 Europe Oncology In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
Table 21 Europe Others In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Region, 2018-2032 (Usd Thousand)
Table 22 Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Vector Type, 2018-2032 (Usd Thousand)
Table 23 Europe Small Molecule Ligands In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Region, 2018-2032 (Usd Thousand)
Table 24 Europe Peptides In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Region, 2018-2032 (Usd Thousand)
Table 25 Europe Monoclonal Antibodies In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Region, 2018-2032 (Usd Thousand)
Table 26 Europe Others In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Region, 2018-2032 (Usd Thousand)
Table 27 Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market, By End User, 2018-2032 (Usd Thousand)
Table 28 Europe Hospitals In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Region, 2018-2032 (Usd Thousand)
Table 29 Europe Hospitals In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
Table 30 Europe Radiopharmacies In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Region, 2018-2032 (Usd Thousand)
Table 31 Europe Research Institutes In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Region, 2018-2032 (Usd Thousand)
Table 32 Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Country, 2018-2032 (Usd Thousand)
Table 33 Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Isotope, 2018-2032 (Usd Thousand)
Table 34 Europe Beta Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
Table 35 Europe Alpha Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
Table 36 Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Sources, 2018-2032 (Usd Thousand)
Table 37 Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Therapeutic Application, 2018-2032 (Usd Thousand)
Table 38 Europe Oncology In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
Table 39 Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Vector Type, 2018-2032 (Usd Thousand)
Table 40 Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market, By End User, 2018-2032 (Usd Thousand)
Table 41 Europe Hospitals In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
Table 42 Germany Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Isotope, 2018-2032 (Usd Thousand)
Table 43 Germany Beta Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
Table 44 Germany Alpha Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
Table 45 Germany Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Sources, 2018-2032 (Usd Thousand)
Table 46 Germany Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Therapeutic Application, 2018-2032 (Usd Thousand)
Table 47 Germany Oncology In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
Table 48 Germany Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Vector Type, 2018-2032 (Usd Thousand)
Table 49 Germany Alpha And Beta Emitters Based Radiopharmaceuticals Market, By End User, 2018-2032 (Usd Thousand)
Table 50 Germany Hospitals In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
Table 51 U.K. Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Isotope, 2018-2032 (Usd Thousand)
Table 52 U.K. Beta Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
Table 53 U.K. Alpha Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
Table 54 U.K. Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Sources, 2018-2032 (Usd Thousand)
Table 55 U.K. Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Therapeutic Application, 2018-2032 (Usd Thousand)
Table 56 U.K. Oncology In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
Table 57 U.K. Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Vector Type, 2018-2032 (Usd Thousand)
Table 58 U.K. Alpha And Beta Emitters Based Radiopharmaceuticals Market, By End User, 2018-2032 (Usd Thousand)
Table 59 U.K. Hospitals In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
Table 60 France Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Isotope, 2018-2032 (Usd Thousand)
Table 61 France Beta Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
Table 62 France Alpha Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
Table 63 France Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Sources, 2018-2032 (Usd Thousand)
Table 64 France Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Therapeutic Application, 2018-2032 (Usd Thousand)
Table 65 France Oncology In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
Table 66 France Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Vector Type, 2018-2032 (Usd Thousand)
Table 67 France Alpha And Beta Emitters Based Radiopharmaceuticals Market, By End User, 2018-2032 (Usd Thousand)
Table 68 France Hospitals In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
Table 69 Italy Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Isotope, 2018-2032 (Usd Thousand)
Table 70 Italy Beta Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
Table 71 Italy Alpha Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
Table 72 Italy Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Sources, 2018-2032 (Usd Thousand)
Table 73 Italy Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Therapeutic Application, 2018-2032 (Usd Thousand)
Table 74 Italy Oncology In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
Table 75 Italy Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Vector Type, 2018-2032 (Usd Thousand)
Table 76 Italy Alpha And Beta Emitters Based Radiopharmaceuticals Market, By End User, 2018-2032 (Usd Thousand)
Table 77 Italy Hospitals In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
Table 78 Spain Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Isotope, 2018-2032 (Usd Thousand)
Table 79 Spain Beta Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
Table 80 Spain Alpha Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
Table 81 Spain Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Sources, 2018-2032 (Usd Thousand)
Table 82 Spain Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Therapeutic Application, 2018-2032 (Usd Thousand)
Table 83 Spain Oncology In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
Table 84 Spain Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Vector Type, 2018-2032 (Usd Thousand)
Table 85 Spain Alpha And Beta Emitters Based Radiopharmaceuticals Market, By End User, 2018-2032 (Usd Thousand)
Table 86 Spain Hospitals In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
Table 87 Poland Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Isotope, 2018-2032 (Usd Thousand)
Table 88 Poland Beta Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
Table 89 Poland Alpha Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
Table 90 Poland Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Sources, 2018-2032 (Usd Thousand)
Table 91 Poland Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Therapeutic Application, 2018-2032 (Usd Thousand)
Table 92 Poland Oncology In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
Table 93 Poland Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Vector Type, 2018-2032 (Usd Thousand)
Table 94 Poland Alpha And Beta Emitters Based Radiopharmaceuticals Market, By End User, 2018-2032 (Usd Thousand)
Table 95 Poland Hospitals In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
Table 96 Russia Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Isotope, 2018-2032 (Usd Thousand)
Table 97 Russia Beta Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
Table 98 Russia Alpha Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
Table 99 Russia Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Sources, 2018-2032 (Usd Thousand)
Table 100 Russia Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Therapeutic Application, 2018-2032 (Usd Thousand)
Table 101 Russia Oncology In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
Table 102 Russia Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Vector Type, 2018-2032 (Usd Thousand)
Table 103 Russia Alpha And Beta Emitters Based Radiopharmaceuticals Market, By End User, 2018-2032 (Usd Thousand)
Table 104 Russia Hospitals In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
Table 105 Norway Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Isotope, 2018-2032 (Usd Thousand)
Table 106 Norway Beta Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
Table 107 Norway Alpha Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
Table 108 Norway Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Sources, 2018-2032 (Usd Thousand)
Table 109 Norway Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Therapeutic Application, 2018-2032 (Usd Thousand)
Table 110 Norway Oncology In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
Table 111 Norway Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Vector Type, 2018-2032 (Usd Thousand)
Table 112 Norway Alpha And Beta Emitters Based Radiopharmaceuticals Market, By End User, 2018-2032 (Usd Thousand)
Table 113 Norway Hospitals In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
Table 114 Turkey Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Isotope, 2018-2032 (Usd Thousand)
Table 115 Turkey Beta Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
Table 116 Turkey Alpha Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
Table 117 Turkey Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Sources, 2018-2032 (Usd Thousand)
Table 118 Turkey Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Therapeutic Application, 2018-2032 (Usd Thousand)
Table 119 Turkey Oncology In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
Table 120 Turkey Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Vector Type, 2018-2032 (Usd Thousand)
Table 121 Turkey Alpha And Beta Emitters Based Radiopharmaceuticals Market, By End User, 2018-2032 (Usd Thousand)
Table 122 Turkey Hospitals In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
Table 123 Austria Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Isotope, 2018-2032 (Usd Thousand)
Table 124 Austria Beta Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
Table 125 Austria Alpha Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
Table 126 Austria Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Sources, 2018-2032 (Usd Thousand)
Table 127 Austria Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Therapeutic Application, 2018-2032 (Usd Thousand)
Table 128 Austria Oncology In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
Table 129 Austria Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Vector Type, 2018-2032 (Usd Thousand)
Table 130 Austria Alpha And Beta Emitters Based Radiopharmaceuticals Market, By End User, 2018-2032 (Usd Thousand)
Table 131 Austria Hospitals In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
Table 132 Ireland Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Isotope, 2018-2032 (Usd Thousand)
Table 133 Ireland Beta Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
Table 134 Ireland Alpha Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
Table 135 Ireland Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Sources, 2018-2032 (Usd Thousand)
Table 136 Ireland Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Therapeutic Application, 2018-2032 (Usd Thousand)
Table 137 Ireland Oncology In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
Table 138 Ireland Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Vector Type, 2018-2032 (Usd Thousand)
Table 139 Ireland Alpha And Beta Emitters Based Radiopharmaceuticals Market, By End User, 2018-2032 (Usd Thousand)
Table 140 Ireland Hospitals In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
Table 141 Netherlands Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Isotope, 2018-2032 (Usd Thousand)
Table 142 Netherlands Beta Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
Table 143 Netherlands Alpha Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
Table 144 Netherlands Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Sources, 2018-2032 (Usd Thousand)
Table 145 Netherlands Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Therapeutic Application, 2018-2032 (Usd Thousand)
Table 146 Netherlands Oncology In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
Table 147 Netherlands Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Vector Type, 2018-2032 (Usd Thousand)
Table 148 Netherlands Alpha And Beta Emitters Based Radiopharmaceuticals Market, By End User, 2018-2032 (Usd Thousand)
Table 149 Netherlands Hospitals In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
List Of Figures
Figure 1 Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market: Segmentation
Figure 2 Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market: Data Triangulation
Figure 3 Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market: Droc Analysis
Figure 4 Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market: Europe Vs Regional Market Analysis
Figure 5 Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market: Company Research Analysis
Figure 6 Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market: Multivariate Modelling
Figure 7 Curve Line Chart, By Isotope
Figure 8 Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market: Interview Demographics
Figure 9 Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market: Dbmr Market Position Grid
Figure 10 Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market: Vendor Share Analysis
Figure 11 Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market: End User Market Coverage Grid
Figure 12 Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market: Segmentation
Figure 13 Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market: Executive Summary
Figure 14 Strategic Decisions
Figure 15 Two Segments Comprise The Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Isotope 2024
Figure 16 Increased Efficacy Of Targeted Alpha And Beta Therapies Is Expected To Drive The Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market In The Forecast Period
Figure 17 Beta Emitters Segment Is Expected To Account For The Largest Share Of The Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market In 2025 & 2032
Figure 18 Incidence By Cancer Site
Figure 19 Cancer Mortality Rate With Cancer Site
Figure 20 Droc Analysis
Figure 21 Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market: By Isotope, 2024
Figure 22 Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market: By Isotope, 2025 To 2032 (Usd Thousand)
Figure 23 Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market: By Isotope, Cagr (2025-2032)
Figure 24 Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market: By Isotope, Lifeline Curve
Figure 25 Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market: By Sources, 2024
Figure 26 Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market: By Sources, 2025 To 2032 (Usd Thousand)
Figure 27 Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market: By Sources, Cagr (2025-2032)
Figure 28 Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market: By Sources, Lifeline Curve
Figure 29 Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market: By Therapeutic Application, 2024
Figure 30 Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market: By Therapeutic Application, 2025 To 2032 (Usd Thousand)
Figure 31 Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market: By Therapeutic Application, Cagr (2025-2032)
Figure 32 Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market: By Therapeutic Application, Lifeline Curve
Figure 33 Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market: By Vector Type, 2024
Figure 34 Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market: By Vector Type, 2025 To 2032 (Usd Thousand)
Figure 35 Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market: By Vector Type, Cagr (2025-2032)
Figure 36

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us